NCT04585750 2026-03-12The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PMV Pharmaceuticals, IncPhase 1/2 Recruiting300 enrolled
NCT07229313 2026-03-10A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsKivu Bioscience Inc.Phase 1 Recruiting76 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT06305962 2026-02-19177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, LtdPhase EARLY_PHASE1 Recruiting30 enrolled